Owens & Minor Inc. Stock
€24.40
Your prediction
Owens & Minor Inc. Stock
Pros and Cons of Owens & Minor Inc. in the next few years
Pros
Cons
Performance of Owens & Minor Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Owens & Minor Inc. | 4.270% | 0.862% | 7.339% | 100.000% | 33.714% | -24.075% | - |
Orasure Tech | -0.890% | -8.130% | -11.719% | 5.607% | -24.161% | -35.429% | -41.872% |
scPharmaceuticals | -0.440% | -8.097% | -16.697% | -41.419% | -21.043% | -18.929% | - |
SI-BONE Inc | 2.920% | -6.803% | -20.809% | 17.094% | -27.895% | -45.200% | - |
Comments
News
Owens & Minor Reports Fourth Quarter and Full Year 2023 Financial Results
Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2023.
Full Year 2023 Key Highlights:
-
Consolidated revenue of $10.3 billion
Owens & Minor Announces Fourth Quarter 2023 Earnings Release Date and Conference Call
Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the fourth quarter of 2023 on Tuesday, February 20, 2024, before trading begins on the New York Stock Exchange.
The Company
Owens & Minor Unveils Long-Term Strategy at Investor Day Today
Owens & Minor, Inc. (NYSE-OMI) (the “Company”), a global healthcare solutions company that provides healthcare products for home-based care, self-manufactured products, proprietary product